CYCLOPHOSPHAMIDE FOR INJECTION USP DIN 02570467
Health Canada record
| Active ingredient(s) | CYCLOPHOSPHAMIDE 1000 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01AA01 CYCLOPHOSPHAMIDE |
| Original market date | |
| Current status date | 31-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Formative Pharma Inc. — licence 3-002652, currently licensed, last inspection rating C (2023-10-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CYCLOPHOSPHAMIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02559994 | CYCLOPHOSPHAMIDE FOR INJECTION | DR REDDY'S LABORATORIES LTD | Solution | CYCLOPHOSPHAMIDE 500 MG | Approved |
| 02560224 | CYCLOPHOSPHAMIDE FOR INJECTION USP | MARCAN PHARMACEUTICALS INC | Powder For Solution | CYCLOPHOSPHAMIDE 2000 MG | Marketed |
| 02560216 | CYCLOPHOSPHAMIDE FOR INJECTION USP | MARCAN PHARMACEUTICALS INC | Powder For Solution | CYCLOPHOSPHAMIDE 1000 MG | Marketed |
| 02560208 | CYCLOPHOSPHAMIDE FOR INJECTION USP | MARCAN PHARMACEUTICALS INC | Powder For Solution | CYCLOPHOSPHAMIDE 500 MG | Approved |
| 02546744 | CYCLOPHOSPHAMIDE FOR INJECTION USP | ANDONE PHARMACEUTICAL INC | Powder For Solution | CYCLOPHOSPHAMIDE 2000 MG | Marketed |
| 02546736 | CYCLOPHOSPHAMIDE FOR INJECTION USP | ANDONE PHARMACEUTICAL INC | Powder For Solution | CYCLOPHOSPHAMIDE 1000 MG | Marketed |
| 02547694 | CYCLOPHOSPHAMIDE FOR INJECTION USP | STERIMAX INC | Powder For Solution | CYCLOPHOSPHAMIDE 2000 MG | Marketed |
| 02547686 | CYCLOPHOSPHAMIDE FOR INJECTION USP | STERIMAX INC | Powder For Solution | CYCLOPHOSPHAMIDE 1000 MG | Marketed |
| 02547678 | CYCLOPHOSPHAMIDE FOR INJECTION USP | STERIMAX INC | Powder For Solution | CYCLOPHOSPHAMIDE 500 MG | Approved |
| 02570459 | CYCLOPHOSPHAMIDE FOR INJECTION USP | FORMATIVE PHARMA INC. | Powder For Solution | CYCLOPHOSPHAMIDE 500 MG | Approved |
| 02570475 | CYCLOPHOSPHAMIDE FOR INJECTION USP | FORMATIVE PHARMA INC. | Powder For Solution | CYCLOPHOSPHAMIDE 2000 MG | Approved |
| 02241800 | PROCYTOX | BAXTER CORPORATION | Powder For Solution | CYCLOPHOSPHAMIDE 2000 MG | Marketed |
| 02241795 | PROCYTOX | BAXTER CORPORATION | Tablet | CYCLOPHOSPHAMIDE 25 MG | Marketed |
| 02241796 | PROCYTOX | BAXTER CORPORATION | Tablet | CYCLOPHOSPHAMIDE 50 MG | Marketed |
| 02241797 | PROCYTOX | BAXTER CORPORATION | Powder For Solution | CYCLOPHOSPHAMIDE 200 MG | Marketed |
| 02241798 | PROCYTOX | BAXTER CORPORATION | Powder For Solution | CYCLOPHOSPHAMIDE 500 MG | Marketed |
| 02241799 | PROCYTOX | BAXTER CORPORATION | Powder For Solution | CYCLOPHOSPHAMIDE 1000 MG | Marketed |
| 02531038 | CYCLOPHOSPHAMIDE FOR INJECTION | ACCORD HEALTHCARE INC | Powder For Solution | CYCLOPHOSPHAMIDE 1000 MG | Cancelled Pre Market |
| 02531046 | CYCLOPHOSPHAMIDE FOR INJECTION | ACCORD HEALTHCARE INC | Powder For Solution | CYCLOPHOSPHAMIDE 2000 MG | Cancelled Pre Market |
| 02531011 | CYCLOPHOSPHAMIDE FOR INJECTION | ACCORD HEALTHCARE INC | Powder For Solution | CYCLOPHOSPHAMIDE 500 MG | Cancelled Pre Market |
| 00602833 | CYTOXAN PWS FOR INJ 1000MG/VIAL | BRISTOL-MYERS SQUIBB CANADA | Powder For Solution | CYCLOPHOSPHAMIDE 1000 MG | Cancelled Post Market |
| 00602949 | CYTOXAN PWS FOR INJ 2000MG/VIAL | BRISTOL-MYERS SQUIBB CANADA | Powder For Solution | CYCLOPHOSPHAMIDE 2000 MG | Cancelled Post Market |
| 00344877 | CYTOXAN TAB 25MG | BRISTOL-MYERS SQUIBB CANADA | Tablet | CYCLOPHOSPHAMIDE 25 MG | Cancelled Post Market |
| 00344885 | CYTOXAN TAB 50MG | BRISTOL-MYERS SQUIBB CANADA | Tablet | CYCLOPHOSPHAMIDE 50 MG | Cancelled Post Market |
| 02094428 | PROCYTOX FOR INJECTION 2000MG PWS IV | CARTER-HORNER CORP. | Powder For Solution | CYCLOPHOSPHAMIDE 2 G; SODIUM CHLORIDE 900 MG | Cancelled Post Market |
| 00373753 | PROCYTOX PWS 500MG | CARTER-HORNER CORP. | Powder For Solution | CYCLOPHOSPHAMIDE 500 MG | Cancelled Post Market |
| 00262676 | PROCYTOX TAB 25MG | CARTER-HORNER CORP. | Tablet | CYCLOPHOSPHAMIDE 25 MG | Cancelled Post Market |
| 00013749 | PROCYTOX TABLETS 50MG | CARTER-HORNER CORP. | Tablet | CYCLOPHOSPHAMIDE 50 MG | Cancelled Post Market |
| 00013552 | PROCYTOX VIAL 1000MG | CARTER-HORNER CORP. | Powder For Solution | CYCLOPHOSPHAMIDE 1 G | Cancelled Post Market |
| 00013544 | PROCYTOX VIAL 200MG | CARTER-HORNER CORP. | Powder For Solution | CYCLOPHOSPHAMIDE 200 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 38035 | 2026-07-31 | Abbreviated New Drug Submission (ANDS) |
International API supply for CYCLOPHOSPHAMIDE
16 active FDA Drug Master Files.
Request a quote for CYCLOPHOSPHAMIDE FOR INJECTION USP